Five Prime Therapeutics (anti-immunosuppression drug) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Five Prime Therapeutics (anti-immunosuppression drug) General Information

Description

The anti-immune-suppression drug is a a anti body that blocks a tumor. The asset is a antibody drug which blocks a tumor that that blunts an immune response to cancer cells. This drug is created for the treatment of cancer.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Primary Office
  • South San Francisco, CA 94080
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Five Prime Therapeutics (anti-immunosuppression drug) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Five Prime Therapeutics (anti-immunosuppression drug)‘s full profile, request access.

Request a free trial

Five Prime Therapeutics (anti-immunosuppression drug) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Five Prime Therapeutics (anti-immunosuppression drug)‘s full profile, request access.

Request a free trial